190 related articles for article (PubMed ID: 2312962)
1. Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway?
Fujimura O; Klein GJ; Yee R; Sharma AD
J Am Coll Cardiol; 1990 Apr; 15(5):1082-6. PubMed ID: 2312962
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation in patients with an accessory pathway: importance of the conduction properties of the accessory pathway.
Della Bella P; Brugada P; Talajic M; Lemery R; Torner P; Lezaun R; Dugernier T; Wellens HJ
J Am Coll Cardiol; 1991 May; 17(6):1352-6. PubMed ID: 2016453
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
Waspe LE; Brodman R; Kim SG; Fisher JD
Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
[TBL] [Abstract][Full Text] [Related]
5. New observations on atrial fibrillation before and after surgical treatment in patients with the Wolff-Parkinson-White syndrome.
Chen PS; Pressley JC; Tang AS; Packer DL; Gallagher JJ; Prystowsky EN
J Am Coll Cardiol; 1992 Apr; 19(5):974-81. PubMed ID: 1552122
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway.
Sharma AD; Klein GJ; Guiraudon GM; Milstein S
Circulation; 1985 Jul; 72(1):161-9. PubMed ID: 4006127
[TBL] [Abstract][Full Text] [Related]
7. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
[TBL] [Abstract][Full Text] [Related]
8. Transesophageal versus intracardiac atrial stimulation in assessing anterograde conduction properties of the accessory pathway in Wolff-Parkinson-White syndrome.
Favale S; Minafra F; Massari V; Tritto M; Rizzon P
Int J Cardiol; 1991 Feb; 30(2):209-14. PubMed ID: 2010244
[TBL] [Abstract][Full Text] [Related]
9. [Atrial fibrillation in Wolff-Parkinson-White syndrome. Development and therapy].
Duckeck W; Kuck KH
Herz; 1993 Feb; 18(1):60-6. PubMed ID: 8454253
[TBL] [Abstract][Full Text] [Related]
10. Ventricular fibrillation in the Wolff-Parkinson-White syndrome.
Klein GJ; Bashore TM; Sellers TD; Pritchett EL; Smith WM; Gallagher JJ
N Engl J Med; 1979 Nov; 301(20):1080-5. PubMed ID: 492252
[TBL] [Abstract][Full Text] [Related]
11. Atrial electrophysiological features in patients with Wolff-Parkinson-White and atrial fibrillation: absence of rate adaptation of intraatrial conduction time parameters.
Riccardi R; Gaita F; Giustetto C; Gardiol S
Pacing Clin Electrophysiol; 1997 May; 20(5 Pt 1):1318-27. PubMed ID: 9170133
[TBL] [Abstract][Full Text] [Related]
12. Preexcited reciprocating tachycardia in patients with Wolff-Parkinson-White syndrome: incidence and mechanisms.
Bardy GH; Packer DL; German LD; Gallagher JJ
Circulation; 1984 Sep; 70(3):377-91. PubMed ID: 6744541
[TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
14. Encainide for atrial fibrillation associated with Wolff-Parkinson-White syndrome.
Rinkenberger RL; Naccarelli GV; Miles WM; Markel ML; Dougherty AH; Prystowsky EN; Heger JJ; Zipes DP
Am J Cardiol; 1988 Dec; 62(19):26L-30L. PubMed ID: 3144164
[TBL] [Abstract][Full Text] [Related]
15. Interaction between accessory pathways resulting in inability to induce reciprocating tachycardia.
Fleck RP; Chen PS; Boyce K; Henjum S; Brennan E; Feld GK
Pacing Clin Electrophysiol; 1993 Feb; 16(2):360-7. PubMed ID: 7680468
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms for the genesis of paroxysmal atrial fibrillation in the Wolff Parkinson-White syndrome: intrinsic atrial muscle vulnerability vs. electrophysiological properties of the accessory pathway.
Centurión OA; Shimizu A; Isomoto S; Konoe A
Europace; 2008 Mar; 10(3):294-302. PubMed ID: 18308751
[TBL] [Abstract][Full Text] [Related]
18. [Different degrees of risk of high-frequency atrial fibrillation in symptomatic and asymptomatic WPW syndrome. Electrophysiologic evaluation].
Delise P; D'Este D; Bonso A; Raviele A; Di Pede F; Millosevich P; Livio A; Piccolo E
G Ital Cardiol; 1987 Feb; 17(2):127-33. PubMed ID: 3609615
[TBL] [Abstract][Full Text] [Related]
19. [Atrial desynchronization induced by Valsalva's maneuver in a patient with reciprocating supraventricular tachycardia and Wolff-Parkinson-White syndrome].
Martini B; Buja GF; Canciani B; Maddalena F; Nava A
G Ital Cardiol; 1987 Oct; 17(10):830-3. PubMed ID: 3436495
[TBL] [Abstract][Full Text] [Related]
20. Frequency of recurrent atrial fibrillation after catheter ablation of overt accessory pathways.
Haissaguerre M; Fischer B; Labbé T; Lemétayer P; Montserrat P; d'Ivernois C; Dartigues JF; Warin JF
Am J Cardiol; 1992 Feb; 69(5):493-7. PubMed ID: 1736613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
